Elsbernd Brian's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Nov 14, 2025
- Accession no.
- 0001161697-25-000374
- Filed
- Nov 14, 2025
- Trade date
- Nov 12, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $908.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Elsbernd BrianCIK 0001763511 | Officer (Chief Compliance/Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Common Stock, par value $0.001 per share | SSaleAcquired | +40,000 | $22.70F2 | +$908,000 | 231,039 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents a weighted average price for the shares sold. Shares were sold in a range from $22.55 to $23.00 per share.
Referenced by the price of 1 transaction in Table I.